Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial

医学 支气管肺泡灌洗 肺炎 内科学 细菌性肺炎 随机对照试验 外科 肺
作者
Andrei Darie,Nina Khanna,Kathleen Jahn,Michael Osthoff,Stefano Bassetti,Mirjam Osthoff,Desirée Schumann,Werner C. Albrich,Hans H. Hirsch,Martin Brutsche,Leticia Grize,Michael Tamm,Daiana Stolz
出处
期刊:The Lancet Respiratory Medicine [Elsevier BV]
卷期号:10 (9): 877-887 被引量:161
标识
DOI:10.1016/s2213-2600(22)00086-8
摘要

PCR-based testing has transformed the management of suspected respiratory viral infections. We aimed to determine whether multiplex bacterial PCR of bronchoalveolar lavage fluid aids antibiotic stewardship in patients with pneumonia.This investigator-initiated, multicentre, randomised controlled trial was conducted at two tertiary care centres in Switzerland (University Hospital of Basel and Kantonsspital St Gallen). Patients aged 18 years or older who were admitted to hospital with suspected pneumonia, had a clinical indication for bronchoscopy with bronchoalveolar lavage, and were at risk of Gram-negative bacterial infection were included. Patients were randomly assigned (1:1) to either the multiplex bacterial PCR group or the conventional microbiology control group using a random allocation sequence. Treating physicians were not masked, but the committee panel was masked to patient randomisation. All patients underwent bronchoscopy with bronchoalveolar lavage and samples were assessed by conventional microbiological culture (and additionally, in the PCR group, by multiplex bacterial PCR for Gram-negative rods using the Unyvero Hospitalized Pneumonia [HPN] Cartridge; Curetis, Holzgerlingen, Germany). Patients received empirical antibiotic therapy as clinically indicated by the treating physician. In the PCR group, a recommendation regarding antibiotic therapy was made approximately 5 h after taking the sample. The primary outcome was the time in hours on inappropriate antibiotic therapy from bronchoscopy to discharge or to 30 days after bronchoscopy. This trial was registered with the International Clinical Trials Registry Platform, ISRCTN95828556.Between May 31, 2017, and Sept 25, 2019, 740 patients with pneumonia were screened for eligibility and 208 were included and randomly assigned to the PCR group (n=100) or conventional microbiology control group (n=108). The mean age of patients was 65·9 years (SD 14·0) and 135 (65%) were male. After daily follow-up until hospital discharge or for a maximum of 30 days, the duration of inappropriate antibiotic treatment was significantly shorter by 38·6 h (95% CI 19·5-57·7) in the PCR group than in the control group (adjusted mean 47·1 h [34·7-59·5] vs 85·7 h [78·8-95·6]; p<0·0001), which translates as a decrease in the duration of inappropriate antibiotic therapy of 45·0% (37·9-52·1). Adverse events due to antimicrobial therapy occurred in nine patients (five [5%] in the PCR group vs four [4%] in the control group) and due to bronchoscopy occurred in four patients (two [1%] vs two [1%]). There were eight (8%) deaths in the PCR group and 11 (10%) in the control group. All in-hospital deaths were attributed to a respiratory cause.Multiplex bacterial PCR examination of bronchoalveolar lavage decreases the duration of inappropriate antibiotic therapy of patients admitted to hospital with pneumonia and at risk of Gram-negative rod infection. This approach warrants further consideration in future antibiotic stewardship strategies.Curetis and the Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Switzerland.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero的应助被we采纳,获得10
1秒前
2秒前
高山发布了新的文献求助10
3秒前
天天快乐的应助被张佳琪采纳,获得10
3秒前
3秒前
lawrencewong完成签到,获得积分10
3秒前
4秒前
4秒前
ueaaa完成签到,获得积分10
5秒前
6秒前
神宝嘎li发布了新的文献求助10
6秒前
深情安青的应助被追寻若南采纳,获得10
6秒前
7秒前
诸葛烤鸭发布了新的文献求助10
7秒前
FashionBoy的应助被无情向薇采纳,获得10
7秒前
VDC的应助被研友_qZAze8采纳,获得30
7秒前
随便点发布了新的文献求助10
8秒前
科研通AI6.3的应助被六六采纳,获得10
9秒前
9秒前
9秒前
9秒前
科研通AI6.2的应助被摆渡人采纳,获得10
9秒前
arpege发布了新的文献求助10
10秒前
焦粉蛋挞完成签到 ,获得积分20
10秒前
张伟发布了新的文献求助10
11秒前
11秒前
11秒前
11秒前
九七完成签到 ,获得积分10
11秒前
科研通AI6.2的应助被Lu采纳,获得10
11秒前
12秒前
风吹麦浪的应助被积极的易文采纳,获得10
13秒前
YY发布了新的文献求助10
13秒前
ding的应助被牛牛采纳,获得10
13秒前
NexusExplorer的应助被perper采纳,获得10
14秒前
we发布了新的文献求助10
14秒前
qwer123456发布了新的文献求助10
14秒前
Jasen发布了新的文献求助10
14秒前
陶吉吉不是陶喆完成签到,获得积分10
15秒前
Aulalala完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148